The Antivirals Market is expected to register a CAGR of 2.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Antivirals Market report covers analysis by Product (Bipolar Electrosurgical Devices, Electrosurgical Generator Systems); End User (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Antivirals Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antivirals Market Segmentation
Product- Bipolar Electrosurgical Devices
- Electrosurgical Generator Systems
- Hospitals
- Clinics
- Ambulatory Surgical Centers
Strategic Insights
Antivirals Market Growth Drivers- Increasing Incidence of Viral Infections: The rising incidence of viral infections, including influenza, HIV/AIDS, hepatitis, herpes, and emerging viruses such as COVID-19, is a major driver for the antivirals market. These infections continue to affect millions of people worldwide, and the demand for antiviral treatments is increasing. The emergence of new viral diseases adds to the urgency for effective antiviral therapies, driving market growth.
- Rising awareness and healthcare accessibility: There is growing awareness about viral infections, which might have serious impacts on the individual, and so they want more treatments. Governments and healthcare organizations encourage the early diagnosis and treatment of viral infections and push demand for antivirals. Improved accessibility of healthcare services in emerging markets has also supported the growth in the use of antiviral drugs.
- Technological Advancements in Drug Development: Advancements in biotechnology and pharmacology are enabling the development of more effective and targeted antiviral drugs. Novel antiviral mechanisms, including gene editing, immune modulation, and nanotechnology, are opening up new therapeutic possibilities. This is resulting in the introduction of more advanced antiviral drugs, which is increasing their adoption and broadening the scope of market opportunities.
- Increase in Combination Therapies: Combination therapies, which involve using multiple antiviral agents together, are becoming more common, especially in the treatment of chronic viral infections like HIV and hepatitis C. These combinations are designed to reduce the risk of resistance and enhance the effectiveness of treatment. The trend towards combination therapies is expanding the antivirals market by providing more comprehensive treatment options for patients.
- Emphasis on Antiviral Vaccines: Vaccination remains one of the most effective preventive measures against viral infections. There is a growing trend in the antiviral market towards the development of antiviral vaccines, such as those for influenza, hepatitis, and COVID-19. The development of these vaccines, in addition to antiviral drugs, is a critical component of comprehensive strategies to combat viral infections.
- R&D in Novel Antiviral Drugs: Ongoing research and development efforts are focusing on discovering and developing novel antiviral drugs that target different viral strains, particularly for infections that currently lack effective treatments. Antiviral agents that target viral replication, immune response modulation, and other unique viral mechanisms are showing promise. For instance, in March 2023, Emory University and Pfizer, Inc. entered into a strategic collaboration to accelerate the development of COVID-19 antiviral medication. The key players in the market are collaborating for the R&D of new therapies to reduce the burden of viral infection treatment. This trend is expected to lead to the introduction of new antiviral drugs and further fuel market growth.
- Monoclonal Antibodies and Immune Modulators: Monoclonal antibodies (mAbs) and immune modulators are becoming increasingly important in antiviral therapy, particularly for infections like COVID-19. These biological therapies can help modulate the immune system to combat viral infections more effectively. The growing interest in biologics for antiviral treatments presents a lucrative opportunity for companies specializing in antibody-based therapies.
- Emerging Viruses Prevention and Treatment: There is an emergent need for antiviral drugs due to new viral threats that have recently surfaced, including Zika, Ebola, and coronaviruses. Companies able to rapidly develop effective therapies for emerging viral infections have the opportunity to capture a large share of the market. Another potential for antivirals is to use them in conjunction with vaccines for more comprehensive prevention and treatment options.
- Over-the-Counter Antiviral Medications: The increasing availability of over-the-counter antiviral medications for conditions such as the common cold, influenza, and herpes simplex virus is creating new opportunities for antiviral drug manufacturers. Over-the-counter drugs are appealing to consumers because of their convenience and accessibility. This trend is expected to continue, particularly as the demand for self-care products grows globally.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antivirals Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antivirals Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Antivirals Market are Increasing Incidence of Viral Infections, Rising awareness and healthcare accessibility, and Technological Advancements in Drug Development
The key future trends of the market are Increase in combination therapies, Emphasis on Antiviral Vaccines, and R&D in Novel Antiviral Drugs
The leading players operating in the Antivirals Market include Abbott Laboratories, Boehringer Ingelheim GmbH, Bristol-Myers-Squibb, Broad Institute, F. Hoffmann-La Roche, GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mylan N.V.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Advanced Bipolar Direct Energy Devices Markets - By Product
1.3.2 Advanced Bipolar Direct Energy Devices Markets - By End User
1.3.3 Advanced Bipolar Direct Energy Devices Markets - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ADVANCED BIPOLAR DIRECT ENERGY DEVICES MARKETS LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ADVANCED BIPOLAR DIRECT ENERGY DEVICES MARKETS - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ADVANCED BIPOLAR DIRECT ENERGY DEVICES MARKETS - GLOBAL MARKET ANALYSIS
6.1. ADVANCED BIPOLAR DIRECT ENERGY DEVICES - GLOBAL MARKET OVERVIEW
6.2. ADVANCED BIPOLAR DIRECT ENERGY DEVICES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ADVANCED BIPOLAR DIRECT ENERGY DEVICES MARKETS - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BIPOLAR ELECTROSURGICAL DEVICES
7.3.1. Overview
7.3.2. Bipolar Electrosurgical Devices Market Forecast and Analysis
7.4. ELECTROSURGICAL GENERATOR SYSTEMS
7.4.1. Overview
7.4.2. Electrosurgical Generator Systems Market Forecast and Analysis
8. ADVANCED BIPOLAR DIRECT ENERGY DEVICES MARKETS - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTERS (ASCS)
8.5.1. Overview
8.5.2. Ambulatory Surgical Centers (ASCs) Market Forecast and Analysis
9. ADVANCED BIPOLAR DIRECT ENERGY DEVICES MARKETS REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Advanced Bipolar Direct Energy Devices Markets Overview
9.1.2 North America Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis
9.1.3 North America Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Product
9.1.4 North America Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By End User
9.1.5 North America Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Countries
9.1.5.1 United States Advanced Bipolar Direct Energy Devices Markets
9.1.5.1.1 United States Advanced Bipolar Direct Energy Devices Markets by Product
9.1.5.1.2 United States Advanced Bipolar Direct Energy Devices Markets by End User
9.1.5.2 Canada Advanced Bipolar Direct Energy Devices Markets
9.1.5.2.1 Canada Advanced Bipolar Direct Energy Devices Markets by Product
9.1.5.2.2 Canada Advanced Bipolar Direct Energy Devices Markets by End User
9.1.5.3 Mexico Advanced Bipolar Direct Energy Devices Markets
9.1.5.3.1 Mexico Advanced Bipolar Direct Energy Devices Markets by Product
9.1.5.3.2 Mexico Advanced Bipolar Direct Energy Devices Markets by End User
9.2. EUROPE
9.2.1 Europe Advanced Bipolar Direct Energy Devices Markets Overview
9.2.2 Europe Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis
9.2.3 Europe Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Product
9.2.4 Europe Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By End User
9.2.5 Europe Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Countries
9.2.5.1 Germany Advanced Bipolar Direct Energy Devices Markets
9.2.5.1.1 Germany Advanced Bipolar Direct Energy Devices Markets by Product
9.2.5.1.2 Germany Advanced Bipolar Direct Energy Devices Markets by End User
9.2.5.2 France Advanced Bipolar Direct Energy Devices Markets
9.2.5.2.1 France Advanced Bipolar Direct Energy Devices Markets by Product
9.2.5.2.2 France Advanced Bipolar Direct Energy Devices Markets by End User
9.2.5.3 Italy Advanced Bipolar Direct Energy Devices Markets
9.2.5.3.1 Italy Advanced Bipolar Direct Energy Devices Markets by Product
9.2.5.3.2 Italy Advanced Bipolar Direct Energy Devices Markets by End User
9.2.5.4 Spain Advanced Bipolar Direct Energy Devices Markets
9.2.5.4.1 Spain Advanced Bipolar Direct Energy Devices Markets by Product
9.2.5.4.2 Spain Advanced Bipolar Direct Energy Devices Markets by End User
9.2.5.5 United Kingdom Advanced Bipolar Direct Energy Devices Markets
9.2.5.5.1 United Kingdom Advanced Bipolar Direct Energy Devices Markets by Product
9.2.5.5.2 United Kingdom Advanced Bipolar Direct Energy Devices Markets by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Advanced Bipolar Direct Energy Devices Markets Overview
9.3.2 Asia-Pacific Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis
9.3.3 Asia-Pacific Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Countries
9.3.5.1 Australia Advanced Bipolar Direct Energy Devices Markets
9.3.5.1.1 Australia Advanced Bipolar Direct Energy Devices Markets by Product
9.3.5.1.2 Australia Advanced Bipolar Direct Energy Devices Markets by End User
9.3.5.2 China Advanced Bipolar Direct Energy Devices Markets
9.3.5.2.1 China Advanced Bipolar Direct Energy Devices Markets by Product
9.3.5.2.2 China Advanced Bipolar Direct Energy Devices Markets by End User
9.3.5.3 India Advanced Bipolar Direct Energy Devices Markets
9.3.5.3.1 India Advanced Bipolar Direct Energy Devices Markets by Product
9.3.5.3.2 India Advanced Bipolar Direct Energy Devices Markets by End User
9.3.5.4 Japan Advanced Bipolar Direct Energy Devices Markets
9.3.5.4.1 Japan Advanced Bipolar Direct Energy Devices Markets by Product
9.3.5.4.2 Japan Advanced Bipolar Direct Energy Devices Markets by End User
9.3.5.5 South Korea Advanced Bipolar Direct Energy Devices Markets
9.3.5.5.1 South Korea Advanced Bipolar Direct Energy Devices Markets by Product
9.3.5.5.2 South Korea Advanced Bipolar Direct Energy Devices Markets by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Advanced Bipolar Direct Energy Devices Markets Overview
9.4.2 Middle East and Africa Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis
9.4.3 Middle East and Africa Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Countries
9.4.5.1 South Africa Advanced Bipolar Direct Energy Devices Markets
9.4.5.1.1 South Africa Advanced Bipolar Direct Energy Devices Markets by Product
9.4.5.1.2 South Africa Advanced Bipolar Direct Energy Devices Markets by End User
9.4.5.2 Saudi Arabia Advanced Bipolar Direct Energy Devices Markets
9.4.5.2.1 Saudi Arabia Advanced Bipolar Direct Energy Devices Markets by Product
9.4.5.2.2 Saudi Arabia Advanced Bipolar Direct Energy Devices Markets by End User
9.4.5.3 U.A.E Advanced Bipolar Direct Energy Devices Markets
9.4.5.3.1 U.A.E Advanced Bipolar Direct Energy Devices Markets by Product
9.4.5.3.2 U.A.E Advanced Bipolar Direct Energy Devices Markets by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Advanced Bipolar Direct Energy Devices Markets Overview
9.5.2 South and Central America Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis
9.5.3 South and Central America Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Product
9.5.4 South and Central America Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By End User
9.5.5 South and Central America Advanced Bipolar Direct Energy Devices Markets Forecasts and Analysis - By Countries
9.5.5.1 Brazil Advanced Bipolar Direct Energy Devices Markets
9.5.5.1.1 Brazil Advanced Bipolar Direct Energy Devices Markets by Product
9.5.5.1.2 Brazil Advanced Bipolar Direct Energy Devices Markets by End User
9.5.5.2 Argentina Advanced Bipolar Direct Energy Devices Markets
9.5.5.2.1 Argentina Advanced Bipolar Direct Energy Devices Markets by Product
9.5.5.2.2 Argentina Advanced Bipolar Direct Energy Devices Markets by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ADVANCED BIPOLAR DIRECT ENERGY DEVICES MARKETS, KEY COMPANY PROFILES
11.1. B.BRAUN MELSUNGEN AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOVIE MEDICAL CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CONMED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ETHICON ENDO-SURGERY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. KARL STORZ
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. KLS MARTIN
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MAXER ENDOSCOPY GMBH
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MEDICAL TECHNOLOGIES
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDTRONIC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. OLYMPUS CORPORATION
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Abbott Laboratories
2. Boehringer Ingelheim GmbH
3. Bristol-Myers-Squibb
4. Broad Institute
5. F. Hoffmann-La Roche
6. GlaxoSmithKline plc.
7. Johnson & Johnson Services, Inc.
8. Merck & Co., Inc.
9. Mylan N.V
10. Novartis AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For